Latest Insider Transactions at Intercept Pharmaceuticals, Inc. (ICPT)
This section provides a real-time view of insider transactions for Intercept Pharmaceuticals, Inc. (ICPT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTERCEPT PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTERCEPT PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
Mark Pruzanski Director |
BUY
Grant, award, or other acquisition
|
Direct |
41,236
+7.39%
|
$989,664
$24.7 P/Share
|
|
Dec 31
2020
|
Christian Weyer EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
779
-4.88%
|
$18,696
$24.7 P/Share
|
|
Dec 15
2020
|
Sandip Kapadia CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
1,763
-6.1%
|
$56,416
$32.78 P/Share
|
|
Nov 27
2020
|
Christian Weyer EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
357
-2.19%
|
$13,209
$37.27 P/Share
|
|
Nov 23
2020
|
Jerome Benedict Durso CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-0.82%
|
$11,165
$35.47 P/Share
|
|
Nov 13
2020
|
Ryan T Sullivan General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
493
-1.96%
|
$18,241
$37.87 P/Share
|
|
Nov 12
2020
|
Gail Cawkwell SVP, Med Affairs, Safety & PV |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-1.48%
|
$12,122
$38.52 P/Share
|
|
Nov 08
2020
|
David A Ford Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
128
-0.95%
|
$3,584
$28.15 P/Share
|
|
Oct 01
2020
|
David A Ford Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-0.68%
|
$3,864
$42.08 P/Share
|
|
Oct 01
2020
|
Sandip Kapadia CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
296
-1.01%
|
$12,432
$42.08 P/Share
|
|
Oct 01
2020
|
Richard J Kim President US Comm & Strat Mktg |
SELL
Payment of exercise price or tax liability
|
Direct |
223
-1.06%
|
$9,366
$42.08 P/Share
|
|
Oct 01
2020
|
Mark Pruzanski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
772
-0.16%
|
$32,424
$42.08 P/Share
|
|
Oct 01
2020
|
Christian Weyer EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
46
-0.28%
|
$1,932
$42.08 P/Share
|
|
Oct 01
2020
|
Jerome Benedict Durso CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
289
-0.73%
|
$12,138
$42.08 P/Share
|
|
Oct 01
2020
|
Jason Campagna Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
112
-1.29%
|
$4,704
$42.08 P/Share
|